A study of the dopamine D2 receptor gene in pathological gambling

Pharmacogenetics

Volumn 6, Issue 3, 1996, Pages 223-234

  Comings, David E ^a   Rosenthal, Richard J ^b   Lesieur, Henry R ^c   Rugle, Loreen J ^d   Muhleman, Donn ^a   Chiu, Connie ^a   Dietz, George ^a   Gade, Radhika ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Dept Crim Justice Sci I ^*  (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

ADHD; Alcoholism; Dopamine; DRD2; DRD3; Drug abuse; Pathological gambling

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DRD3 PROTEIN, HUMAN;

ADDICTION; ADULT; ALCOHOLISM; ALLELE; ARTICLE; BEHAVIOR; CAUCASIAN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENE; HUMAN; IMPULSIVENESS; MAJOR CLINICAL STUDY; MALE; PATHOLOGICAL GAMBLING; PATHOLOGY; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SUBSTANCE ABUSE; UNITED STATES; DEPRESSION; DRINKING BEHAVIOR; GENETICS; MIDDLE AGED; MOTIVATION; ONSET AGE; RELIGION;

ADULT; AGE OF ONSET; ALCOHOL DRINKING; ALLELES; DEPRESSION; GAMBLING; HUMANS; MIDDLE AGED; MOTIVATION; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; RELIGION; SUBSTANCE-RELATED DISORDERS;

EID: 0029661582     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-199606000-00004     Document Type: Article

References (68)

1. Amadeo S, Abbar M, Fourcade ML, Waksman G, Leroux MG, Madec A, Selin M, Champiat J-C, Brethome A, Leclaire Y, Castelnau D, Venisse J-L, Mallet J. D2 dopamine receptor gene and alcoholism. J Psychiatr Res 1993: 27, 173-179.
2. Anden NE, Atack CV, Svensen TH. Release of dopamine from central noradenaline and dopamine nerves by a dopamine b-hydroxylase inhibitor. J Neural Transm 1973: 34, 93-100.
3. Barr CL, Kidd KK. Population frequencies of the A1 allele at the dopamine D2 receptor locus. Biol Psychiatry 1993: 34, 204-209.
4. Blaszcynski A, McConaghy N, Frankova A. Crime, antisocial personality and pathological gambling. J Gambling Behavior 1989: 5, 137-152.
5. Blum K, Noble EP, Sheridan PJ, Montgomery A, Ritchie T, Jadadeeswaran P, Nogami H, Briggs AH, Cohn JB. Allelic association of human dopamine D2 receptor gene in alcoholism. J Am Med Assn 1990: 263, 2055-2059.
6. Blum K, Braverman ER, Wood RC, Gill J. Li C, Chen TJH, Taub M, Montgomery AR, Sheridan PJ. Increased prevalence of the Taq I A1- allele of the dopamine D2 receptor gene (DRD2) in obesity with comorbid polysubstance abuse. Pharmacogenetics 1996: (in press).
7. Bolos AM, Dean M, Lucas-Derse S, Ramsburg M, Brown GL, Goldman D. Population and pedigree studies reveal a lack of association between the dopamine D2 receptor gene and alcoholism. J Am Med Assn 1990: 26, 3156-3160.
8. Brett P, Robertson M, Gurling H, Curtis D. Failure to find linkage and increased homozygosity for the dopamine D3 receptor gene in Tourette syndrome. Lancet 1993: 341, 1225.
9. Cagle M, Peacock ML, Mathay JG, Sunnenberg C, Tandon R, Meltzer H, Fink JK. Dopamine D3 receptor polymorphism in schizophrenia: Importance of evaluating controls subjects. Am J Hum Genet 1993: 53, A780.
10. Carlton PL, Goldstein L. Physiological determinants of pathological gambling. In: Galski T. ed. Handbook on pathological gambling. Springfield, IL: Charles C. Thomas Publisher, 1987.
11. Carlton PL, Manowitz P, McBride H, Nora R, Swartzburg M, Goldstein L. Attention deficit disorder and pathological gambling. J Clin Psychiatry 1987: 48, 487-488.
12. Comings DE. Tourette syndrome and human behavior. Duarte, CA: Hope Press 1990: 1-828.
13. Comings DE. Genetic factors in substance abuse based on studies of Tourette syndrome and ADHD probands and relatives. I. Drug abuse, Drug Alcohol Depend 1994a: 35, 1-16.
14. Comings DE. The role of genetic factors in human sexual behavior based on studies of Tourette syndrome and ADHD probands and their relatives. Am J Med Gen (Neuropsych Genet) 1994b: 54, 227-241.
15. Comings DE. Genetic factors in substance abuse based on studies of Tourette syndrome and ADHD probands and relatives. II. Alcohol abuse, Drug Alcohol Depend 1994c: 35, 17-24.
16. Comings DE. Tourette syndrome: A hereditary neuropsychiatric spectrum disorder. Ann Clin Psychiatry 1995a: 6, 235-247.
17. Comings DE. 1995b: Genetic mechanisms in neuropsychiatric disorders. In: Blum K, Noble EP, Sparks RS, Sheridan, PJ, eds. Handbook of psychoneurogenetics. Boca Raton, FL: CRC Press 1996b (in press).
18. Comings DE. The haplotype relative risk technique lacks power in polygenic inheritance. 1995 World Congress Psychiatric Genetics 1995c: 5, 103.
19. Comings DE. The role of genetic factors in conduct disorder based on studies of Tourette syndrome and ADHD probands and their relatives. J Dev Behav Pediatr 1995d: 16, 142-157.
20. Comings DE. Genetic factors in depression based on studies of Tourette syndrome and attention deficit hyperactivity disorder probands and relatives. Am J Med Gen (Neuropsych Genet) 1995e: 60, 111-121.
21. Comings DE, Comings BG, Muhleman D, Dietz G, Shahbahrami B, Tast D, Knell E, Kocsis P, Baumgarten R, Kovacs BW, Levy DL, Smith M, Kane JM, Lieberman JA, Klein DN, MacMurray J, Tosk J, Sverd J, Gysin R, Flanagan S. The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders. J Am Med Assn 1991: 266, 1793-1800.
22. Comings DE, Flanagan SD, Dietz G, Muhleman D, Knell E, Gysin R. The dopamine D2 receptor (DRD2) as a major gene in obesity and height. Biochem Med Metabolic Biol 1993a: 50, 176-185.
23. Comings DE, Muhleman D, Dietz G, Dino M, Legro R, Gade R. Association between Tourette's syndrome and homozygosity at the dopamine-D3 receptor gene. Lancet 1993b: 341, 906.
24. Comings DE, Muhleman D, Dietz G., Dino M, Legro R, Gade R. Tourette's syndrome and homozygosity for the dopamine D3 receptor gene - reply. Lancet 1993c: 341, 1483-1484.
25. Comings DE, Muhleman D, Ahn C, Gysin R, Flanagan SD. The dopamine D2 receptor gene: a genetic risk factor in substance abuse. Drug Alcohol Depend 1994: 34, 175-180.
26. Comings DE, Ferry L, Bradshaw-Robinson S, Burchette R, Chiu C, Muhleman D. The dopamine D2 receptor (DRD2) gene: a genetic risk factor in smoking. Pharmacogenetics 1996: 6, 73-79.
27. Comings DE, Muhleman D, Gysin R. The dopamine D2 receptor (DRD2) gene in posttraumatic stress disorder: a study and replication. Biol Psychiatry 1996: (in press).
28. Crocq M-A, Mant R, Asherson P, Williams J, Hode Y, Mayerova A, Collier D, Lannfelt L, Sokoloff P, Schwartz J-C, Gil M, Macher J-P, Mcguffin P, Owen MJ. Association between schizophrenia and homozygosity at the dopamine D3 receptor gene. J Med Genet 1992: 29, 858-860.
29. Diagnostic and statistical manual of mental disorders. Third edition - revised. Washington, DC: American Psychiatric Association, 1987.
30. Diagnostic and statistical manual of the American Psychiatric Assn. IV. Washington, DC: American Psychiatric Assn, 1994.
31. Falk CT, Rubinstein P. Haplotype relative risks: an easy reliable way to construct a proper control sample for risk calculations. Ann Hum Genet 1987: 51, 227-233.
32. Gadow KD, Sprafkin J. Child symptom inventories manual. Stony Brook, NY: Checkmate Plus, Ltd. 1994: 1-115.
33. 2 receptor gene in alcoholism or schizophrenia. J Am Med Assn 1994: 271, 204-208.
34. Goldman D, Brown GL, Albaugh B, Robin R, Goodson S, Trunzo M, Akhtar L, Lucas-Derse S, Linnoila M, Dean M. DRD2 dopamine receptor genotype, linkage disequilibrium, and alcoholism in American Indians and other populations. Alcoholism: Clin Exp Res 1993: 17, 199-204.
35. Grandy DK, Litt M, Allen L, Bunzow JR, Marchionni M, Makam H, Reed L, Magenis RE, Civelli O. The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a Taq I RFLP. Am J Hum Genet 1989: 45, 778-785.
36. Grayson P, Carlson G. The utility of a DSM-III-R based checklist in screening child psychiatric patients. J Am Acad Child Adolesc Psychiatry 1991: 30, 669-673.
37. Hebebrand J, Nöthen MM, Lehmkuhl G, Poustka F, Schmidt M, Propping P, Remschmidt H. Tourette's syndrome and homozygosity for the dopamine D3 receptor gene. Lancet 1993: 341, 1483.
38. Lesieur HR. The chase: career of the compulsive gambler. Garden City NY: Anchor Books, 1977.
39. Lesieur HR, Heineman M. Pathological gambling among youthful multiple substance abusers in a therapeutic community. Br J Addict 1988: 83, 765-771.
40. Lesieur HR, Blume SB, Zoppa RM. Alcoholism, drug abuse and gambling. Alcoholism: Clin Exp Res 1984: 10, 33-38.
41. Levinson PK, Gerstein DR, Maloff DR. Commonalities in substance abuse and habitual behaviors. (1983): Lexington Books. Lexington.
42. Linden RD, Pope HG, Jonas SM. Pathological gambling and major affective disorder: Preliminary findings. J Clin Psychiatry 1986: 47, 201-203.
43. McCormick RA, Russo AM, Ramirez LF, Taber JI. Affective disorders among pathological gamblers seeking treatment. Am J Psychiatry 1984: 141, 215-218.
44. Miller WR. The addictive behaviors. Oxford: Pergamon Press, 1980.
45. Moran E. Varieties of pathological gambling. Br J Psychiatry 1970: 116, 593-597.
46. Nimgaonkar VL, Zhang XR, Caldwell JG, Ganguli R, Chakravarti A. Association with the dopamine D3 receptor gene locus among schizophrenic patients with a family history of schizophrenia. Am J Hum Genet 1993: 53, A838.
47. Noble EP, Blum K, Ritchie T, Montgomery A, Sheridan PJ. Allelic association of the D2 dopamine receptor gene with receptorbinding characteristics in alcoholism. Arch Gen Psychiatry 1991: 48, 648-654.
48. Noble EP. The D2 dopamine receptor gene: A review of association studies in alcoholism. Behav Genet 1993: 23 119-129.
49. 2 dopamine receptor gene with cocaine dependence. Drug Alcohol Depend 1993a: 33, 271-285.
50. Noble EP, Noble RE, Ritchie T, Grandy DK, Sparkes RS, Allelic association of the D2 dopamine receptor gene with obesity. Am J Hum Genet 1993b: 53, A117.
51. O'Hara BF, Smith SS, Bird G, Persico AM, Suarez B, Cutting GR, Uhl GR. Dopamine D2 receptor RFLPs, haplotypes and their association with substance use in Black and Caucasian research volunteers. Hum Genet 1993: 43, 209-218.
52. Parsian A, Todd RD, Devor EJ, O'Malley KL, Suarez BK, Reich T. Cloninger CR. Alcoholism and alleles of the human dopamine D2 receptor locus. Studies of association and linkage. Arch Gen Psychiatry 1991: 48, 655-663.
53. Ramirez LF, McCormick RA, Russo AM, et al. Patterns of substance abuse in pathological gamblers undergoing treatment. Addict Behav 1984: 8, 425-428.
54. Robins LN, Helzer J, Croughan J, Ratclif KS. National Institute of Health diagnostic interview schedule. Arch Gen Psychiatry 1981: 38, 381-389.
55. Rosenthal RJ. The pathological gambler's system of self-deception. J Gambling Behavior 1986: 2, 108-120.
56. Rosenthal Rj, Lesieur HR. Self-reported withdrawal symptoms and pathological gambling. Am J Addict 1992: 1, 150-152.
57. Rugle L, Melamed, L. Neuropsychological assessment of attention problems in pathological gamblers. J Nerv Ment Dis 1993: 181, 107-112.
58. Russo AM. The relationship between pathological gambling and narcissism. Masters Thesis. (1987): Ohio University.
59. Sanders AR, Hamilton JD, Fann WE, Patel PI. Association of genetic variation at the porphobilinogen deaminase gene with schizophrenia. Am J Hum Genet 1991: 49 (Suppl), 358A.
60. Sarkar G, Kapelner S, Grandy DK, Marchionni M, Civelli O, Sobell J, Heston L, Sommer SS. Direct sequencing of the dopamine D2 receptor (DRD2) in schizophrenics reveals three polymorphisms but no structural change in the receptor. Genomics 1991: 11, 8-14.
61. Schwab S. Soyka M, Niederecker N, Ackenheil M, Scherer J, Widenauer DB. Allelic association of human dopamine D2-receptor DNA polymorphism ruled out in 45 alcoholics. Am J Hum Genet 1991: 49 (suppl), 203A.
62. Smith SS, O'Hara BF, Persico AM, Gorelick DA, Newlin DB, Vlahov D. Solomon L, Pickins R, Uhl GR. Genetic vulnerability to drug abuse. The D2 dopamine receptor Taq I B1 restriction fragment length polymorphism appears more frequently in polysubstance abusers. Arch Gen Psychiatry 1992: 49, 723-727.
63. 2 dopamine receptor locus (DRD2) in alcoholics and controls. Genomics 1994: 19, 12-20.
64. Todd RD, O'Malley K, Parsian A, Simpson SG, DePaulo R. Bipolar affective disorder and alleles of the tyrosine hydroxylase locus. Psychiat Genet 1991: 2, 47-48.
65. 2 dopamine receptor gene alleles in substance abuse. Arch Gen Psychiatry 1992a: 49, 157-160.
66. Uhl GR, Smith SS, O'Hara BF, Persico AM, Bird GS, Markham LL. Taq I A and B D2 receptor RFLPs in polysubstance abusers. C I N P XVIIIth Congress 1992b: Nice June 28-July 2. (Abstract).
67. Volberg RA. The prevalence and demographics of pathological gamblers: implications for public health. Am J Public Health 1994: 84, 237-241.
68. Wray I, Dickerson MG. Cessation of high frequency gambling and 'withdrawal' symptoms. Br J Addict 1981: 76, 401-405.